IN

Instadose Pharma CorpOOTC INSD Stock Report

Last reporting period 28 Feb, 2022

Updated 01 Nov, 2024

Last price

Market cap $B

0.001

Micro

Exchange

OOTC - OTC

INSD Stock Analysis

IN

Uncovered

Instadose Pharma Corp is uncovered by Eyestock quantitative analysis.

Market cap $B

0.001

Dividend yield

Shares outstanding

531.93 B

Website

Instadose Pharma Corp. engages in the designing, manufacturing and selling of micro-furniture that transforms any small space, particularly apartments and condominiums into functional spaces. The company is headquartered in Chesapeake, Virginia. The company went IPO on 2019-03-07. The Company, through its wholly owned subsidiary, Instadose Canada is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil (Global Distribution Platform). Instadose Canada’s Global Distribution Platform spans five (5) continent, including Africa, Europe, Asia, South America, and North America. Its Global Distribution Platform functions include Organizing, managing, and sourcing the transport of medicinal cannabis from medicinal cannabis cultivation Participants to one or more cannabinoid oil production participants; selling all medicinal cannabis and cannabinoid oil cultivated and/or produced by global distribution platform participants to pharmaceutical industry companies; and sourcing new medicinal cannabis cultivation and cannabinoid oil production participants across new and existing continents. Its subsidiaries include Instadose Pharma, LDA and Instadose Pharma, LDA.

View Section: Eyestock Rating